Merontos, Angelic H.

HRN: 22-47-45  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/10/2023
CEFTRIAXONE 1G (VIAL)
01/10/2023
01/16/2023
IV
2g
OD
Intraabdominal Infection
Waiting Final Action 
01/12/2023
AZITHROMYCIN 500MG TABLET (TAB)
01/12/2023
01/18/2023
PO
500mg
Q24
Bacteremia
Waiting Final Action 
01/13/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/13/2023
01/19/2023
IV INFUSION
1.5g
Q8
T/C Psoas Abscess
Waiting Final Action 
01/13/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/13/2023
01/20/2023
IV INFUSION
500mg
Q8
T/C Psoas Abscess
Waiting Final Action 
01/17/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/17/2023
01/23/2023
IV
4.5g
Q8H
Pelvic Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: